Company profile for Solu Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Solu Therapeutics, a precision-medicine company, is developing therapeutics to eliminate disease-driving cells in cancer, immunology, and autoimmunity. The proprietary CyTaC (Cytotoxicity Targeting Chimera) platform and drug candidates, licensed from GSK, unlock antibody-intractable cell surface targets providing the capability to develop next-generation medicines that harness the power of biologics with the vast target bindin...
Solu Therapeutics, a precision-medicine company, is developing therapeutics to eliminate disease-driving cells in cancer, immunology, and autoimmunity. The proprietary CyTaC (Cytotoxicity Targeting Chimera) platform and drug candidates, licensed from GSK, unlock antibody-intractable cell surface targets providing the capability to develop next-generation medicines that harness the power of biologics with the vast target binding space of small molecules.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
15 Necco Street, 7th Floor, Boston, MA 02210, United States
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/solu-therapeutics-to-present-first-preclinical-data-of-stx-0712-for-the-treatment-of-chronic-myelomonocytic-leukemia-and-acute-myeloid-leukemia-at-ash-annual-meeting-302317441.html

PR NEWSWIRE
02 Dec 2024

https://www.prnewswire.com/news-releases/solu-therapeutics-strengthens-leadership-team-with-appointment-of-sergio-santillana-md-as-chief-medical-officer-302243220.html

PR NEWSWIRE
10 Sep 2024

https://www.businesswire.com/news/home/20240319208421/en

BUSINESSWIRE
19 Mar 2024

https://www.businesswire.com/news/home/20230911137362/en

BUSINESSWIRE
11 Sep 2023

https://www.businesswire.com/news/home/20230815464221/en

BUSINESSWIRE
15 Aug 2023

https://www.businesswire.com/news/home/20230801108191/en

BUSINESSWIRE
01 Aug 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty